United Kingdom - Re-Import of Heparin for Therapeutic Use
Since 2014, United Kingdom Re-Import of Heparin for Therapeutic Use was down by 13.2% year on year. With $5,416.76 in 2019, the country was number 7 among other countries in Re-Import of Heparin for Therapeutic Use. United Kingdom is overtaken by New Zealand, which was ranked number 6 at $40,139.76 and is followed by South Africa at $62.85. Canada topped the ranking with $1,738,281.5 in 2019, that is +72.9% compared to 2018. Australia, China and France respectively ranked number 2, 3 and 4 in this ranking. Australia recorded the best 5 years average growth at +309.1% per year, while Thailand was the worst growing country at -47.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 5,416.76 |
| 2018 | 46,167.94 |
| 2017 | 12,191.04 |
| 2016 | 2,000.00 |
| 2015 |
Download all data from 2000 to 2019
How does United Kingdom rank in Re-Import of Heparin for Therapeutic Use?
| # | 9 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Canada
|
1,738,281.50 | 2019 | +72.9 % | +112.5 % | View data | |
| 2 |
#2
Australia
|
1,253,862.50 | 2019 | +10.8 % | +309.1 % | View data | |
| 6 |
#6
New Zealand
|
40,139.76 | 2019 | +27.3 % | +60.2 % | View data | |
| 7 |
#7
United Kingdom
|
5,416.76 | 2019 | -88.3 % | -13.2 % | View data | |
| 8 |
#8
South Africa
|
62.84 | 2018 | NA | NA | View data | |